Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04989049
Other study ID # folic acid for oral ulcers
Secondary ID
Status Not yet recruiting
Phase Early Phase 1
First received
Last updated
Start date September 2022
Est. completion date December 2022

Study information

Verified date March 2022
Source Dow University of Health Sciences
Contact Tahseen S Khooharo, MSc oral medicine
Phone +923362533399
Email tahseen_shabbir@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

patients reporting at the department of oral medicine with the complain of oral ulceration will be asked to participate in this study.


Description:

Oral ulcerations are usually reported with pain and discomfort while eating and drinking at times while talking. Ulcers are usually described as erythematous surroundings, raised margins, with yellowish-white necrotic pseudomembranous centre. Healing process of ulcers usually starts nearly after 24-48 h of its onset. The initial inflammatory stage is enriched by leukocytes, after 48 hours of injury, mature monocytes in connective tissue turn into macrophages which until day 3 tend to increase in numbers. Oral ulcers are one of the commonest lesions of oral cavity; around 83.6% people have suffered from the ulcers. Frequency of traumatic ulcers fluctuates from 3 to 34% around the globe. Traumatic ulcers are usually caused by mechanical irritaation. Various studies have been conducted till date for the treatment of oral ulcers such as anti-inflammatory gels, propolis extract gel, topical steroids such as triamcinolone acetonide paste and silver nanoparticle gel. Folic acid (vitamin b9) belongs to the water soluble class of vitamins called B-complex. It is an essential component of metabolic pathways of carbohydrates, fats and proteins which are important compounds in various functions such as cardiovascular and nervous system. This vitamin is also important for DNA methylation and biosynthesis of nucleotide. Dietary foliate deficiency is a problem of developing country. Folic acid daily requirement of an adult is 400 mg/day whereas during pregnancy it's required up to 600mg and in nursing mother daily required dosage of foliate is 500mg/day. The difference between folic acid and foliate is that the foliate is a natural form which is found in mushrooms, green leafy vegetables and livers whereas folic acid is synthetically produced and is used to fortify processed foods and supplements in a fully reduced biologically active form dihydrofolate reductase. Humans lack the enzyme which is required to produce foliate that is why they depend on dietary and supplemental form of this essential vitamin. Main objective while treating the ulcers is to reduce the discomfort and accelerate healing. Thus the purpose of the study is to find out therapeutic role of topical folic acid on oral ulcerations. Patients falling in the inclusion criteria will be asked to participate in the study, consent will be obtained from the patients. Demographic feature, history and examination will be noted on a research questionnaire. After examination patients will be given topical folic acid in tablet form to be applied by themselves twice a day on ulcers. Patients will be asked to visit the dental out patients department of oral medicine at Isra University Hyderabad on 7th day for follow up. Specific questions will be asked from the patients and examination will be done on the day of follow, the information will be recorded on a follow up form.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 75
Est. completion date December 2022
Est. primary completion date November 2022
Accepts healthy volunteers No
Gender All
Age group 14 Years to 44 Years
Eligibility Inclusion Criteria: - • Age of the participant will be between 14 to 44 years old - Both of the genders will be included - Patients with oral ulceration Exclusion Criteria: - • Reluctant to participate - Non healing ulcerations, lasting for more than 14 days after removing the cause - Patients with neurological problems, psoriasis, rheumatoid arthritis.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Folic Acid 5 MG
folic acid tablet of 5mg will be placed on the ulcers 2 times per day for 7 days
Other:
placebo
an inactive drug looking exactly like active drug will be given, patients will be asked to put it on ulcers 2 times per day

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Dow University of Health Sciences

Outcome

Type Measure Description Time frame Safety issue
Primary healing of ulcers patients will be examined to evaluate if the ulcers are healed completely, follow up questionnaire form will be filled by the examining dentist, describing the condition of the patient. 7 days
See also
  Status Clinical Trial Phase
Completed NCT03239834 - Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making
Completed NCT06379438 - Treatment of Aphtous Ulcers With Photodynamic Therapy N/A
Withdrawn NCT02769494 - The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral Ulcer Phase 3
Completed NCT05413096 - Combination of Diclofenac Potassium and Propolis in the Therapy of Oral Aphthosis Early Phase 1
Completed NCT03633292 - Aloe Vera and Chlorhexidine Against Traumatic Oral Ulcers Phase 4
Completed NCT00333749 - The Effectiveness of Pasteurized Goat Milk in the Treatment of Childhood Oral Ulcer Diseases Phase 1
Recruiting NCT04710888 - Basil Extract (Ocimum Basilicum) in the Management of Recurrent Aphthous Stomatitis Phase 2
Completed NCT05147376 - Effectiveness of a Curcumin Mouthwash in Preventing Traumatic Ulcers in Patients With Fixed Orthodontic Appliances Early Phase 1
Completed NCT04383236 - Probiotic Lozenges for Treatment of Recurrent Aphthous Stomatitis N/A
Completed NCT03167632 - Oral Ulcer Prevalence: Hospital-based Cross-sectional Study N/A
Enrolling by invitation NCT05288478 - Dose-ranging Study of Dentoxol® Mouthrinse for Managing Oral Symptoms in People With Epidermolysis Bullosa. Phase 2
Recruiting NCT05449548 - Lenalidomide in the Treatment of Mucosal Behçet's Syndrome N/A
Completed NCT05032248 - Uses of Tacrolimus in Behcet Disease N/A